Published in
Elsevier, The Lancet Oncology, 5(22), p. 665-677, 2021
DOI: 10.1016/s1470-2045(21)00064-4
Links
Tools
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial
Journal article published in 2021 by
Thierry Andre,
Mayur Amonkar,
Josephine M. Norquist,
Kai-Keen Shiu,
Tae Won Kim,
Benny Vittrup Jensen,
Lars Henrik Jensen,
Cornelis J. A. Punt,
Denis Smith,
Rocio Garcia-Carbonero,
Isabel Sevilla,
Christelle De La Fouchardiere 
,
Fernando Rivera,
Elena Elez ,
Luis A. Diaz
and other authors.
,
Fernando Rivera,
Elena Elez ,
Luis A. Diaz
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 